These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21244216)

  • 1. Nanobody; an old concept and new vehicle for immunotargeting.
    Rahbarizadeh F; Ahmadvand D; Sharifzadeh Z
    Immunol Invest; 2011; 40(3):299-338. PubMed ID: 21244216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumors with nanobodies for cancer imaging and therapy.
    Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
    J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the study of natural small molecular antibody].
    Zhu L; Zhang DP
    Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first antibody therapy for cancer: a personal experience.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2013 Apr; 13(4):399-406. PubMed ID: 23560835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The future of antibody fragments, made of a single immunoglobulin domain].
    Chames P; Baty D
    Med Sci (Paris); 2009 Dec; 25(12):1159-62. PubMed ID: 20035698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
    Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
    Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for cancer: construction, expression and functional characterization of chimeric antibodies.
    Motmans K; Thirion S; Heyligen H; Janssens J; Raus J; Vandevyver C
    Eur J Cancer Prev; 1996 Dec; 5(6):512-9. PubMed ID: 9061286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody guided precision radiation therapy.
    Brady ED; Milenic DE; Brechbiel MW
    Discov Med; 2004 Jun; 4(22):213-9. PubMed ID: 20704989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
    Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
    J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel single-chain variable fragment antibody against FGF-1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF-1.
    Shi HL; Yang T; Deffar K; Dong CG; Liu JY; Fu CL; Zheng DX; Qin B; Wang JJ; Wang XZ; Zhu XJ
    IUBMB Life; 2011 Feb; 63(2):129-37. PubMed ID: 21360642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
    Cazin JL; Gosselin P; Demaille A
    Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.
    Skrlj N; Serbec VC; Dolinar M
    Appl Biochem Biotechnol; 2010 Mar; 160(6):1808-21. PubMed ID: 19597999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of nanobody in cancer treatment].
    Wu Y; Hao X; Li M
    Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1085-1090. PubMed ID: 28869728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.